The relief of dry eye signs and symptoms using a combination of lubricants, lid hygiene and ocular nutraceuticals / Alivio de los síntomas y signos del ojo seco con el uso de una combinación de lubricantes, productos para higiene palpebral y nutracéuticos oculares

Purpose: To determine the combined effect of TheraTears® Lubricant Eye Drops, TheraTears® SteriLid Eyelid Cleanser, and TheraTears® Nutrition on dry eye signs and symptoms. Methods: This prospective study enrolled 28 dry eye participants. Participants were instructed to use the Lubricant Eye Drops at least 2-4✕ a day, SteriLid 1-2✕ a day, and Nutrition 3 gel caps once a day. Participants were followed up at baseline, 1 month and 3 months. Outcome variables were the Ocular Surface Disease Index (OSDI), Symptom Assessment iN Dry Eye (SANDE) questionnaire, non-invasive tear break-up time (NIBUT), osmolarity, number of meibomian glands blocked (#MG blocked), meibum quality, eyelid margin features, Schirmer’s test, tear film lipid layer thickness (LLT), meniscus height, corneal and conjunctival staining. Results: Twenty participants (mean age = 43, from 23 to 66, 17F, 3M) completed the study. Participants reported having used, on average, the Lubricant Eye Drop 2.4✕/day, the SteriLid 1.1✕/day, and the Nutrition 3 gel caps 1✕/day. There was a significant change over time (p < 0.05) for OSDI (−21.2 points), SANDE (−32.4 points), NIBUT (+0.43 s), eyelid margin features (−1.1 grade), meibum quality (−1.0 grade), and #MG blocked (−4.0 glands). Conclusion: By using a combination of TheraTears® Lubricant Eye Drop, SteriLid, and Nutrition, patients experience significant relief in both dry eye symptoms and signs (AU)

Objetivo: Determinar el efecto combinado de las gotas lubricantes TheraTears®, el limpiador palpebral TheraTears® SteriLid, y TheraTears® Nutrition sobre los signos y síntomas del ojo seco. Métodos: Este estudio prospectivo incluyó a veintiocho participantes con ojo seco, a quienes se solicitó que utilizaran las gotas lubricantes al menos 2-4 veces al día, SteriLid 1-2 veces al día, y las cápsulas Nutrition 3 gel una vez al día. Se realizó un seguimiento al inicio, al cabo de un mes, y a los tres meses. Las variables de los resultados fueron OSDI (Ocular Surface Disease Index), el cuestionario SANDE (Symptom Assessment iN Dry Eye), NIBUT (non-invasive tear break-up time), la osmolaridad, el número de glándulas de Meibomio bloqueadas (#MG bloqueadas), la calidad de la secreción de las glándulas de meibomio, las características del margen palpebral, la prueba de Schirmer, LLT (grosor de la capa lipídica) de la película lagrimal, altura del menisco, y tinción de la córnea y la conjuntiva. Resultados: Veinte participantes (edad media = 43, de 23 a 66, 17M, 3V) completaron el estudio. Los participantes reportaron que habían utilizado, de media, las gotas lubricantes 2,4 veces/día, SteriLid 1,1 veces/día, y las cápsulas Nutrition 3 gel 1 veces/día. No se produjo u cambio significativo a lo largo del tiempo (p < 0,05) en cuanto a OSDI (-21,2 puntos), SANDE (-32,4 puntos), NIBUT (+0,43s), características del margen palpebral (-1,1 grado), calidad de la secreción de las glándulas de meibomio (-1,0 grado), y #MG bloqueadas (-4,0 glándulas). Conclusión: Con el uso de una combinación de gotas lubricantes, SteriLid, y Nutrition, de TheraTears®, los pacientes experimentan un alivio significativo de los síntomas y signos del ojo seco (AU)

The relief of dry eye signs and symptoms using a combination of lubricants, lid hygiene and ocular nutraceuticals.

PURPOSE: To determine the combined effect of TheraTears® Lubricant Eye Drops, TheraTears® SteriLid Eyelid Cleanser, and TheraTears® Nutrition on dry eye signs and symptoms. METHODS: This prospective study enrolled 28 dry eye participants. Participants were instructed to use the Lubricant Eye Drops at least 2-4× a day, SteriLid 1-2× a day, and Nutrition 3 gel caps once a day. Participants were followed up at baseline, 1 month and 3 months. Outcome variables were the Ocular Surface Disease Index (OSDI), Symptom Assessment iN Dry Eye (SANDE) questionnaire, non-invasive tear break-up time (NIBUT), osmolarity, number of meibomian glands blocked (#MG blocked), meibum quality, eyelid margin features, Schirmer's test, tear film lipid layer thickness (LLT), meniscus height, corneal and conjunctival staining. RESULTS: Twenty participants (mean age=43, from 23 to 66, 17F, 3M) completed the study. Participants reported having used, on average, the Lubricant Eye Drop 2.4×/day, the SteriLid 1.1×/day, and the Nutrition 3 gel caps 1×/day. There was a significant change over time (p<0.05) for OSDI (-21.2 points), SANDE (-32.4 points), NIBUT (+0.43s), eyelid margin features (-1.1 grade), meibum quality (-1.0 grade), and #MG blocked (-4.0 glands). CONCLUSION: By using a combination of TheraTears® Lubricant Eye Drop, SteriLid, and Nutrition, patients experience significant relief in both dry eye symptoms and signs.

Effects of a blue light-filtering intraocular lens on driving safety in glare conditions.

PURPOSE: To evaluate whether the previously established benefit of blue light-filtering intraocular lenses (IOLs) when driving in glare conditions is maintained in patients previously implanted with a blue light-filtering toric IOL. SETTING: Department of Applied Psychology, Arizona State University, Mesa, Arizona, USA. DESIGN: Comparative case series. METHODS: The study comprised patients with a blue light-filtering toric IOL (test IOL) or an ultraviolet (UV)-only filtering nontoric IOL (control IOL). All patients had good visual acuity and a valid driver's license. While wearing best spherocylindrical correction, patients performed left-turn maneuvers in front of oncoming traffic in a driving simulator. The safety margin was defined as the time to collision less the time taken to turn at an intersection with oncoming traffic. Measures were repeated with a glare source simulating low-angle sun conditions (daytime driving). RESULTS: Of the 33 evaluable patients, 18 had a test IOL and 15 had a control IOL. In the presence of glare, patients with test IOLs had significantly greater safety margins (mean 2.676 seconds ± 0.438 [SD]) than patients with control IOLs (mean 2.179 ± 0.343 seconds) and significantly lower glare susceptibility (P<.05). In no-glare and glare conditions, patients with test IOLs had significantly lower glare susceptibility than patients with control IOLs. CONCLUSION: The blue light-filtering toric IOL produced a significantly greater reduction in glare disability than the UV-only filtering nontoric IOL and increased the ability of drivers to safely execute left turns in low-sun conditions. FINANCIAL DISCLOSURE: Dr. Houtman is an employee of Alcon Laboratories, Inc. No other author has a financial or proprietary interest in any material or method mentioned.

Visual performance in cataract patients with low levels of postoperative astigmatism: full correction versus spherical equivalent correction.

PURPOSE: To evaluate whether visual performance could be improved in pseudophakic subjects by correcting low levels of postoperative astigmatism. METHODS: An exploratory, noninterventional study was conducted using subjects who had been implanted with an aspheric intraocular lens and had 0.5-0.75 diopter postoperative astigmatism. Monocular visual performance using full correction was compared with visual performance using spherical equivalent correction. Testing consisted of high- and low-contrast visual acuity, contrast sensitivity, and reading acuity and speed using the Radner Reading Charts. RESULTS: Thirty-eight of 40 subjects completed testing. Visual acuities at three contrast levels (100%, 25%, and 9%) were significantly better using full correction than when using spherical equivalent correction (all P < 0.001). For contrast sensitivity testing under photopic, mesopic, and mesopic with glare conditions, only one out of twelve outcomes demonstrated a significant improvement with full correction compared with spherical equivalent correction (at six cycles per degree under mesopic without glare conditions, P = 0.046). Mean reading speed was numerically faster with full correction across all print sizes, reaching statistical significance at logarithm of the reading acuity determination (logRAD) 0.2, 0.7, and 1.1 (P < 0.05). Statistically significant differences also favored full correction in logRAD score (P = 0.0376), corrected maximum reading speed (P < 0.001), and logarithm of the minimum angle of resolution/logRAD ratio (P < 0.001). CONCLUSIONS: In this study of pseudophakic subjects with low levels of postoperative astigmatism, full correction yielded significantly better reading performance and high- and low-contrast visual acuity than spherical equivalent correction, suggesting that cataractous patients may benefit from surgical correction of low levels of preoperative corneal astigmatism.